Kidney Stones Therapeutic Market by Type, End-user, and Geography - Forecast and Analysis 2023-2027

Published: Mar 2023

Pages: 161

SKU: IRTNTR71823

Snapshot

Kidney Stones Therapeutic Market Forecast 2023-2027

The global Kidney Stones Therapeutic market size is forecasted to increase by USD 566.78 million at a CAGR of 5.42% between 2022 and 2027. The growth of the market depends on several factors, including the growing popularity of flexible digital ureteroscopes, the rising incidence of urolithiasis, and the increasing prevalence of kidney stone disease.

What will be the Size of the Kidney Stones Therapeutic Market during the Forecast Period?

To learn more about this report, Download Report Sample

Kidney Stones Therapeutic Market Segmentation

This report extensively covers market segmentation by type (ureteroscopy, lithotripsy, and percutaneous nephrolithotomy (PCNL)), end-user (hospitals, specialty clinics, and ambulatory surgical centers), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

By Type

The market growth by the ureteroscopy segment will be significant during the forecast period. Ureteroscopy, which is also known as intracorporeal lithotripsy and retrograde intrarenal surgery (RIRS), is used if the stone size is up to 15 mm-20 mm in diameter and has moved into the ureter. This procedure has a high success rate when compared to lithotripsy.

Get a glance at the market contribution of various segments Request a PDF Sample

The ureteroscopy segment was valued at USD 772.74 million in 2017 and continued to grow by 2021. Vendors in the US offer technologically advanced ureteroscopes. For instance, Boston Scientific Corporation offers LithoVue single-use digital flexible ureteroscope, which delivers detailed high-resolution digital images. The use of single-use digital ureteroscopes in hospitals and clinics has increased when compared to reusable ureteroscopes due to the high capital expense of buying reusable ureteroscopes. The number of ureteroscopy procedures is estimated to account for more than half of the kidney stone treatment surgeries performed worldwide. Therefore, the URS segment is expected to dominate the global s market during the forecast period.

Kidney Stones Therapeutic Market Dynamic

The rising incidence of urolithiasis is notably driving the market growth, although factors such as the shortage of skilled professionals may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Driver

The rising incidence of urolithiasis among the global population is driving the market growth.
Urolithiasis, which is also known as kidney stone disease, refers to the deposition of minerals and salts inside the kidneys or the urinary tract.
The number of people with urolithiasis is increasing due to changes in lifestyles and food intake, which is increasing the demand for urolithiasis treatment devices.
An estimated 1% to 13% of the population in different regions has urolithiasis.
Ureteroscopic laser lithotripsy is a common treatment of urolithiasis, as it reduces the procedure time as well as the number of sittings and eliminates.
Thus, the rising incidence of urolithiasis among the global population is expected to positively impact the growth of the market during the forecast period.

Significant Trend

The rising geriatric population is a key trend influencing the market growth.
The geriatric population faces several health issues, which will influence healthcare spending patterns in developed and developing countries.
In the US, the number of people aged 65 years and above is expected to more than double by 2060, which will increase the demand for healthcare and age-related services.
The geriatric population is prone to conditions such as urolithiasis. Hence, the adoption of kidney stone therapeutics is expected to increase.
These factors are expected to drive market growth during the forecast period.

Major Challenge

The shortage of skilled professionals may impede the market growth.
Procedures such as kidney stone removal and prostatectomy are highly complex and require trained professionals.
However, countries such as India, China, US are facing a shortage of skilled surgeons.
Therefore, effective training for surgeries, especially laparoscopic and robotic-assisted surgeries, is crucial.
There has been a decrease in the number of urologists globally, and this number is projected to decline by nearly 30% by 2025.
This is because fewer doctors are opting for the urology specialty and the number of experienced surgeons nearing retirement has increased.
Therefore, the decrease in the number of urologists will hinder the market's growth during the forecast period.

Key Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Who are the Major Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Anvik Biotech - The company offers a kidney stone therapeutic, namely Pitonac.

Intas Pharmaceuticals Ltd.- The company offers CNS, Cardiovascular, Diabetology, Gastroenterology, Urology, and Oncology medical products.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Which are the Key Regions for the Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The North American market growth is attributed to high demand for superior medical technology, increasing adoption of minimally invasive treatment options such as URS, the region's existing advanced medical infrastructure, and strong market presence of major providers.

In Canada, approximately 100,000 people out of every million will develop kidney stones at some point in their lives. Increasing public and private healthcare spending is also boosting the market growth. Moreover, the proportion of medical expenditures spent on treating kidney stones is steadily increasing in the region. North America dominates the market in terms of revenue and is expected to maintain its position over the forecast period. Canada accounts the large share of the North American market due to the rising prevalence of kidney stone disease, demand for high-quality medical technology, and increasing investment in the development of advanced.

Market Analyst Overview

Kidney stones, including calcium oxalate stones, uric acid stones, struvite stones, and cystine stones, present a significant healthcare concern globally. Diagnosis methods such as ultrasound, CT scans, and X-rays play a crucial role in identifying these stones, enabling treatment decisions. Treatment options range from medications to minimally invasive procedures like shock wave lithotripsy and ureteroscopy.

As the prevalence of kidney stones rises, driven by factors like fast food consumption and demographic shifts such as the aging population, there's a growing demand for therapeutic solutions. This trend has led to technological advancements in medical devices and diagnostic tools, facilitating minimally invasive surgical procedures. However, challenges such as high treatment costs and the recurrence of kidney stones remain, prompting ongoing efforts in research and development. Recent innovations, like Dornier MedTech's OptiVision technology, aim to address these challenges, enhancing the efficacy and accessibility of kidney stone treatment worldwide.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Type Outlook (USD Million, 2017 - 2027)
- Ureteroscopy
- Lithotripsy
- Percutaneous nephrolithotomy (PCNL)
End-user Outlook (USD Million, 2017 - 2027)
- Hospitals
- Specialty clinics
- Ambulatory surgical centers
Region Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of World
  - Brazil
  - Australia
  - South Africa

Kidney Stones Therapeutic Market Scope
Report Coverage	Details
Page number	161
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 5.42%
Market growth 2023-2027	USD 566.78 million
Market structure	Fragmented
YoY growth 2022-2023(%)	4.5
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 43%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Anvik Biotech, Aristo Pharma GmbH, Bausch Health Co Inc., Biomedix Siomond Pharma, Cipla Ltd., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Walter Bushnell, Windlas Biotech Pvt. Ltd., Worth Medicines Pvt. Ltd., Pfizer Inc., and Bayer AG
Market dynamics	Parent market analysis, Market forecasting, Market growth and forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our market trends and analysis report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request Market Research Report PDF sample

What are the Key Data Covered in this Market Research and Growth Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the market analysis and report between 2023 and 2027
Precise estimation of the size of the market size and its contribution to the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
Thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive market growth analysis of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global kidney stones market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global kidney stones market 2017 - 2021 ($ million)

4.2 Type Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)

4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type

6.3 Ureteroscopy - Market size and forecast 2022-2027
- Exhibit 34: Chart on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Ureteroscopy - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Ureteroscopy - Year-over-year growth 2022-2027 (%)

6.4 Lithotripsy - Market size and forecast 2022-2027
- Exhibit 38: Chart on Lithotripsy - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Lithotripsy - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Lithotripsy - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Lithotripsy - Year-over-year growth 2022-2027 (%)

6.5 Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027
- Exhibit 42: Chart on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)

6.6 Market opportunity by Type
- Exhibit 46: Market opportunity by Type ($ million)
- Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 48: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 49: Data Table on End-user - Market share 2022-2027 (%)

7.2 Comparison by End-user
- Exhibit 50: Chart on Comparison by End-user
- Exhibit 51: Data Table on Comparison by End-user

7.3 Hospitals - Market size and forecast 2022-2027
- Exhibit 52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

7.4 Specialty clinics - Market size and forecast 2022-2027
- Exhibit 56: Chart on Specialty clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Specialty clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Specialty clinics - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Specialty clinics - Year-over-year growth 2022-2027 (%)

7.5 Ambulatory surgical centers - Market size and forecast 2022-2027
- Exhibit 60: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)

7.6 Market opportunity by End-user
- Exhibit 64: Market opportunity by End-user ($ million)
- Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2022-2027 (%)
- Exhibit 68: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 China - Market size and forecast 2022-2027
- Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)

9.9 Germany - Market size and forecast 2022-2027
- Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.10 Canada - Market size and forecast 2022-2027
- Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)

9.11 UK - Market size and forecast 2022-2027
- Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 Anvik Biotech
- Exhibit 115: Anvik Biotech - Overview
- Exhibit 116: Anvik Biotech - Product / Service
- Exhibit 117: Anvik Biotech - Key offerings

12.4 Aristo Pharma GmbH
- Exhibit 118: Aristo Pharma GmbH - Overview
- Exhibit 119: Aristo Pharma GmbH - Product / Service
- Exhibit 120: Aristo Pharma GmbH - Key offerings

12.5 Bausch Health Co Inc.
- Exhibit 121: Bausch Health Co Inc. - Overview
- Exhibit 122: Bausch Health Co Inc. - Business segments
- Exhibit 123: Bausch Health Co Inc. - Key news
- Exhibit 124: Bausch Health Co Inc. - Key offerings
- Exhibit 125: Bausch Health Co Inc. - Segment focus

12.6 Bayer AG
- Exhibit 126: Bayer AG - Overview
- Exhibit 127: Bayer AG - Business segments
- Exhibit 128: Bayer AG - Key news
- Exhibit 129: Bayer AG - Key offerings
- Exhibit 130: Bayer AG - Segment focus

12.7 Cipla Ltd.
- Exhibit 131: Cipla Ltd. - Overview
- Exhibit 132: Cipla Ltd. - Business segments
- Exhibit 133: Cipla Ltd. - Key news
- Exhibit 134: Cipla Ltd. - Key offerings
- Exhibit 135: Cipla Ltd. - Segment focus

12.8 Dr Reddys Laboratories Ltd.
- Exhibit 136: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 137: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 138: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 139: Dr Reddys Laboratories Ltd. - Segment focus

12.9 Emcure Pharmaceuticals Ltd.
- Exhibit 140: Emcure Pharmaceuticals Ltd. - Overview
- Exhibit 141: Emcure Pharmaceuticals Ltd. - Product / Service
- Exhibit 142: Emcure Pharmaceuticals Ltd. - Key offerings

12.10 GlaxoSmithKline Plc
- Exhibit 143: GlaxoSmithKline Plc - Overview
- Exhibit 144: GlaxoSmithKline Plc - Business segments
- Exhibit 145: GlaxoSmithKline Plc - Key offerings
- Exhibit 146: GlaxoSmithKline Plc - Segment focus

12.11 Intas Pharmaceuticals Ltd.
- Exhibit 147: Intas Pharmaceuticals Ltd. - Overview
- Exhibit 148: Intas Pharmaceuticals Ltd. - Product / Service
- Exhibit 149: Intas Pharmaceuticals Ltd. - Key offerings

12.12 Macleods Pharmaceuticals Ltd.
- Exhibit 150: Macleods Pharmaceuticals Ltd. - Overview
- Exhibit 151: Macleods Pharmaceuticals Ltd. - Product / Service
- Exhibit 152: Macleods Pharmaceuticals Ltd. - Key offerings

12.13 Medinova Diagnostic Services Ltd.
- Exhibit 153: Medinova Diagnostic Services Ltd. - Overview
- Exhibit 154: Medinova Diagnostic Services Ltd. - Product / Service
- Exhibit 155: Medinova Diagnostic Services Ltd. - Key offerings

12.14 Pfizer Inc.
- Exhibit 156: Pfizer Inc. - Overview
- Exhibit 157: Pfizer Inc. - Product / Service
- Exhibit 158: Pfizer Inc. - Key news
- Exhibit 159: Pfizer Inc. - Key offerings

12.15 Walter Bushnell
- Exhibit 160: Walter Bushnell - Overview
- Exhibit 161: Walter Bushnell - Product / Service
- Exhibit 162: Walter Bushnell - Key offerings

12.16 Windlas Biotech Pvt. Ltd.
- Exhibit 163: Windlas Biotech Pvt. Ltd. - Overview
- Exhibit 164: Windlas Biotech Pvt. Ltd. - Product / Service
- Exhibit 165: Windlas Biotech Pvt. Ltd. - Key offerings

12.17 Worth Medicines Pvt. Ltd.
- Exhibit 166: Worth Medicines Pvt. Ltd. - Overview
- Exhibit 167: Worth Medicines Pvt. Ltd. - Product / Service
- Exhibit 168: Worth Medicines Pvt. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 169: Inclusions checklist
- Exhibit 170: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 171: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 172: Research methodology
- Exhibit 173: Validation techniques employed for market sizing
- Exhibit 174: Information sources

13.5 List of abbreviations
- Exhibit 175: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

kidney stones market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis